a developer of novel treatments for diseases related to the human microbiome
Industry Biotechnology
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GTCSX | 34.15 | 0.45 | +1.34% |
Glenmede Small Cap Equity Adv | |||
VPRSX | 16.31 | 0.21 | +1.30% |
VY® JPMorgan Small Cap Core Equity R6 | |||
BALPX | 9.62 | 0.04 | +0.42% |
BlackRock Event Driven Equity Inv A | |||
MSVNX | 7.42 | N/A | N/A |
MassMutual Small Company Val R3 | |||
BSIAX | 10.31 | N/A | N/A |
BlackRock Sustainable Intntl Eq Inv A |
A.I.dvisor indicates that over the last year, MCRB has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if MCRB jumps, then ORMP could also see price increases.
Ticker / NAME | Correlation To MCRB | 1D Price Change % | ||
---|---|---|---|---|
MCRB | 100% | +5.43% | ||
ORMP - MCRB | 42% Loosely correlated | -1.36% | ||
RIGL - MCRB | 38% Loosely correlated | +3.42% | ||
AXON - MCRB | 38% Loosely correlated | -0.73% | ||
ATNM - MCRB | 37% Loosely correlated | +2.07% | ||
AMRN - MCRB | 36% Loosely correlated | +0.87% | ||
More |